Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$145.54 - $178.83 $122 Million - $150 Million
-838,500 Reduced 87.24%
122,600 $21.3 Million
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $152 Million - $183 Million
916,000 Added 2031.04%
961,100 $163 Million
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $6.47 Million - $8.54 Million
42,700 Added 1779.17%
45,100 $8.9 Million
Q2 2023

Aug 14, 2023

SELL
$160.94 - $186.23 $1.95 Million - $2.25 Million
-12,100 Reduced 83.45%
2,400 $413,000
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $261,863 - $315,036
1,800 Added 14.17%
14,500 $2.41 Million
Q4 2022

Feb 14, 2023

SELL
$131.14 - $157.47 $2.92 Million - $3.51 Million
-22,300 Reduced 63.71%
12,700 $1.86 Million
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $118,632 - $146,040
-800 Reduced 2.23%
35,000 $5.19 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $85.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.